August 6, 2024: Warmest congratulations to our company on successfully obtaining the veterinary drug production license and the veterinary drug GMP certificate.

Image Name

2024.08.06

August 6, 2024 —— Our company has officially been awarded the certificate issued by the Ministry of Agriculture and Rural Affairs Veterinary Drug Production License and Veterinary Drug GMP Certificate , marking that the company's quality management system and technical capabilities in the veterinary medicine production field have reached the nation's high-standard requirements. During this certification process, our company Immunology Diagnostic Products (Class B) Production Line Successfully passing the on-site GMP inspection for veterinary drugs and being recognized as a qualified production line has laid a solid foundation for the company to further expand into the veterinary diagnostic reagent market.

Veterinary drug GMP (Good Manufacturing Practice) is an internationally recognized quality management standard for veterinary drug production, designed to ensure the safety, efficacy, and controllable quality of veterinary pharmaceutical products. The successful attainment of this certification not only highlights our company's expertise in the field of veterinary drug manufacturing but also underscores our strong commitment to product quality and animal health.

Immunology Diagnostic Products (Class B) Production Line As one of the company’s core production lines, it focuses on the research and development and manufacturing of veterinary diagnostic reagents, with products widely used in areas such as animal disease detection and immune efficacy assessment. The recent GMP certification confirms that this production line meets national regulatory requirements in terms of facility infrastructure, manufacturing processes, and quality control, ensuring a steady and reliable supply of diagnostic products to the market.

The company’s leader stated: “Obtaining the veterinary drug production license and GMP certification this time marks a significant milestone in our company’s development journey. We will seize this opportunity to continuously enhance our technological innovation capabilities, maintain stringent quality control over our products, and deliver even higher-quality diagnostic solutions to the livestock farming and pet healthcare industries—supporting animal disease prevention and management efforts.”

In the future, our company will continue to uphold the philosophy of "quality first, innovation-driven," deepening our research and development as well as production of veterinary medicines and related products, thereby contributing to the industry's high-quality growth.

 

West Mountain

Previous article

From September 1 to 2, 2024, our company successfully passed the CMA on-site assessment, further solidifying the authoritative recognition of our capabilities in laboratory animal testing.

On March 1, 2024, experts from the Suzhou Municipal Bureau of Agriculture and Rural Affairs visited for an inspection. Our company successfully passed the qualification review for Jiangsu Province's certification as a quarantine and testing laboratory specializing in dogs and cats at their place of origin.

Next article

Previous article

On March 1, 2024, experts from the Suzhou Municipal Bureau of Agriculture and Rural Affairs visited for an inspection. Our company successfully passed the qualification review for Jiangsu Province's certification as a quarantine and testing laboratory specializing in dogs and cats at their place of origin.

Next article

On March 1, 2024, experts from the Suzhou Municipal Bureau of Agriculture and Rural Affairs visited for an inspection. Our company successfully passed the qualification review for Jiangsu Province's certification as a quarantine and testing laboratory specializing in dogs and cats at their place of origin.

More information

On May 10, 2025, our company's Nanoyuan facility successfully completed the filing process for the Suzhou P2 laboratory, becoming one of the first organizations in Suzhou city to receive official accreditation.

On May 10, 2025, our company's Nanoyuan facility successfully completed the filing process for the Suzhou P2 laboratory, becoming one of the first organizations in Suzhou city to receive official accreditation.

[Suzhou, May 10, 2025] Recently, our company’s Nano Park facility successfully completed the filing process for its P2 laboratory with the Suzhou Municipal Bureau of Agriculture and Rural Affairs, officially becoming one of the first animal pathogen microbiology laboratories in the entire Suzhou metropolitan area to receive approval under the newly implemented "Jiangsu Province Animal Pathogen Microbiology Laboratory Filing Management Measures" (effective February 1, 2025).

From September 1 to 2, 2024, our company successfully passed the CMA on-site assessment, further solidifying the authoritative recognition of our capabilities in laboratory animal testing.

From September 1 to 2, 2024, our company successfully passed the CMA on-site assessment, further solidifying the authoritative recognition of our capabilities in laboratory animal testing.

Recently, our company successfully passed the on-site expansion review for CMA accreditation, marking official recognition from a national authority of our professional expertise and robust quality management system in the field of laboratory animal testing. The review took place from September 1 to September 2, 2024, during which the expert panel conducted a comprehensive and rigorous assessment of our laboratory animal testing technologies, equipment, personnel, and management systems—ultimately confirming that we meet the relevant CMA standards.

August 6, 2024: Warmest congratulations to our company on successfully obtaining the veterinary drug production license and the veterinary drug GMP certificate.

August 6, 2024: Warmest congratulations to our company on successfully obtaining the veterinary drug production license and the veterinary drug GMP certificate.

August 6, 2024 – Our company has officially obtained the Veterinary Drug Production License and the Veterinary Drug GMP Certificate issued by the Ministry of Agriculture and Rural Affairs, marking that our company’s quality management system and technical capabilities in the veterinary drug manufacturing sector have met the nation’s stringent high-standard requirements. During this certification process, our immunology-based diagnostic product (Class B) production line successfully passed the on-site GMP inspection for veterinary drugs and was recognized as a qualified production line, laying a solid foundation for the company to further expand into the veterinary diagnostic reagent market.